O76083 (PDE9A_HUMAN) Homo sapiens (Human)

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A UniProtKBInterProSTRINGInteractive Modelling

593 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15; Isoform 16); 1 identical sequence: Homo sapiens: A0A0S2Z4T6

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of PDE9 in complex with racemic inhibitor C33homo-2-mer241-566
10049D;ZN;MG;49E;
Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28homo-2-mer241-566
100LUO;ZN;MG;
Crystal structure of phosphodiesterase 9 in complex with (S)-C33homo-2-mer241-566
10049D;ZN;MG;
Crystal structure of PDE9A (E406A) mutant in complex with IBMXhomo-2-mer241-566
99.69IBM;ZN;MG;CL;
Crystal structure of the human Phosphodiesterase 9A catalytic domain complexed with IBMXhomo-2-mer241-566
100ZN;MG;IBM;
Crystal structure of phosphodiesterase 9 in complex with (R)-C33 (6-{[(1R)-1-(4-chlorophenyl)ethyl]…homo-2-mer241-566
10049E;ZN;MG;
Crystal structure of PDE9A(Q453E) in complex with inhibitor BAY73-6691homo-2-mer241-565
99.69PDB;ZN;MG;
Crystal structure of PDE9A(Q453E) in complex with IBMXhomo-2-mer241-565
99.69IBM;ZN;MG;
Human PDE9 in complex with selective inhibitorhomo-2-mer242-565
100ZN;MG;JAR;
human phosphodiestrase-5'GMP complex (EP), produced by soaking with 20mM cGMP+20 mM MnCl2+20 mM MgC…homo-2-mer242-565
100MN;MG;5GP;IBM;FMT;
human phosphodiestrase 9 (inhibited by omitting divalent cation) in complex with cGMPhomo-2-mer242-565
100NA;PCG;IBM;
Crystal structure of the PDE9 catalytic domain in complex with inhibitor 2homo-2-mer245-566
100ZN;MG;9Q9;
Crystal structure of the PDE9 catalytic domain in complex with inhibitor 4ahomo-2-mer246-566
100ZN;MG;EZU;
Crystal structure of the PDE9A catalytic domain in complex with (S)-BAY73-6691homo-2-mer246-566
100ZN;MG;BYE;
Crystal structure of the PDE9A catalytic domain in complex with (R)-BAY73-6691homo-2-mer247-566
100ZN;MG;PDB;
X-RAY STRUCTURE OF PDE9A IN COMPLEX WITH Inhibitor 13Ahomo-2-mer247-561
100ZN;MG;NA;R4I;
Crystal structure of PDE9 in complex with IBMXmonomer241-566
100ZN;MG;IBM;
human phosphodiestrase 9 in complex with cGMP (Zn inhibited)monomer242-565
100ZN;MG;PCG;
Human Phosphodiesterase 9 in complex with product 5'-GMP (E+P complex)monomer242-565
100MN;MG;5GP;
Human pde9 in complex with selective compoundmonomer242-565
100ZN;MG;0WF;
Human phosphodiesterase 9 in complex with inhibitorsmonomer242-565
100ZN;MG;7RG;
human phosphdiesterase 9 substrate complex (ES complex)monomer242-565
100MN;MG;PCG;
Human phosphodiesterase 9 in complex with inhibitormonomer242-565
100ZN;MG;WTC;
Human PDE9 in complex with selective compoundmonomer242-565
100ZN;MG;0WL;
phosphodiesterase-9A in complex with inhibitor 4bmonomer247-562
100ZN;MG;06A;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4y86.1.Ahomo-2-mer0.91241-566
49D;ZN;MG;49E;94.18

15 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24y86.1.Ahomo-2-mer0.91181-506
49D;ZN;MG;49E;100.00
Isoform 34y86.1.Ahomo-2-mer0.91114-439
49D;ZN;MG;49E;100.00
Isoform 44y86.1.Ahomo-2-mer0.91113-438
49D;ZN;MG;49E;100.00
Isoform 54y86.1.Ahomo-2-mer0.91188-513
49D;ZN;MG;49E;95.28
Isoform 64y86.1.Ahomo-2-mer0.91140-465
49D;ZN;MG;49E;100.00
Isoform 74y86.1.Ahomo-2-mer0.9234-359
49D;ZN;MG;49E;100.00
Isoform 84y86.1.Ahomo-2-mer0.91155-480
49D;ZN;MG;49E;100.00
Isoform 94y86.1.Ahomo-2-mer0.9281-406
49D;ZN;MG;49E;99.31
Isoform 104y86.1.Ahomo-2-mer0.9224-349
49D;ZN;MG;49E;100.00
Isoform 114y86.1.Ahomo-2-mer0.91107-432
49D;ZN;MG;49E;100.00
Isoform 124y86.1.Ahomo-2-mer0.91139-464
49D;ZN;MG;49E;91.45
Isoform 134y86.1.Ahomo-2-mer0.91174-499
49D;ZN;MG;49E;100.00
Isoform 144y86.1.Ahomo-2-mer0.91200-525
49D;ZN;MG;49E;100.00
Isoform 154y86.1.Ahomo-2-mer0.91215-540
49D;ZN;MG;49E;93.62
Isoform 164y86.1.Ahomo-2-mer0.91133-458
49D;ZN;MG;49E;100.00